Singapore’s National Precision Medicine programme expands into phase 2, focusing on hereditary cancers and kidney diseases with digital health integration…
JAMA study shows up to 30% cost savings in rural home hospital models
A JAMA Network Open study highlights rural home hospital programs reducing costs by 30%, increasing patient activity, and improving satisfaction,…
What Health Minister Zubir Ahmed’s data revenue plan means for US healthcare data governance
Health Minister Zubir Ahmed’s proposal to monetize the Health Data Research Service raises ethical, cybersecurity, and innovation questions, drawing lessons…
Brainomix 360 study in Lancet reveals 64-minute cut in stroke care delays
AI imaging tool Brainomix 360 reduces door-in-door-out time by 64 minutes and doubles thrombectomy rates, improving patient independence, based on…
What NICE’s AI tools mean for reducing diagnostic delays in bowel cancer
NICE conditionally recommends five AI tools for bowel cancer detection in colonoscopies, based on four-year evidence showing a 20% increase…
Paradromics’ FDA IDE approval reveals accelerated neurotech regulatory pathways
The FDA’s approval of Paradromics’ BCI clinical trial for speech restoration in paralyzed patients highlights advancements in neurotechnology. This analysis…
How virtual hospitalist programs improve patient throughput by 12% in rural settings
Virtual hospitalist models address rural physician shortages by enabling remote admissions and discharges, with data showing 12% throughput gains and…
How NHS DHT safety gaps increase patient risks by 60%
Analysis reveals over 60% of NHS digital health technologies lack rigorous safety data, risking patient harm. Innovations like MHRA’s regulatory…
Study Reveals Critical AI-Human Reasoning Gap In Surgical Training, Sparks Curriculum Overhaul Debates
Recent Stanford and NHS-backed studies show AI surgical tools achieve 81% exam accuracy but miss critical complications, fueling global debates…
MeiraGTx and Hologen partner to integrate generative AI in Parkinson’s gene therapy trial
MeiraGTx and Hologen have announced a $230 million partnership to use generative AI in optimizing clinical trials and manufacturing for…
Cerebras and Mayo Clinic unveil AI foundation model for rheumatoid arthritis drug prediction
Cerebras Systems and Mayo Clinic have developed an AI model that predicts drug efficacy for Rheumatoid Arthritis with 87% accuracy,…
Will 2025 be a ‘technology wake-up call’ for clinicians?
2025 is set to be a transformative year for AI in medicine, with advanced models like GPT-4 reshaping diagnostic workflows.…